X

Vous n'êtes pas connecté

Maroc Maroc - MOUNTAINTODAY.IN - A La Une - 09/Jul 18:28

Non Alcoholic Fatty Liver Disease Pipeline 2024 | Guangdong Raynovent Biotech, Dr. Falk Pharma GmbH, Enyo Pharma, Viking Therapeutics, Sagimet Biosciences, Terns, Sinew Pharma, Madrigal Pharmaceutical

DelveInsight’s, “Non-Alcoholic Fatty Liver Disease Pipeline Insight 2024” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Non-Alcoholic Fatty Liver Disease pipeline landscape. It covers the Non Alcoholic Fatty Liver Disease

Articles similaires

Long-term air pollution exposure and poor lifestyle choices increase risk of non-alcoholic fatty liver disease

news.medical.net - 03/Sep 11:06

Long-term exposure to air pollution and poor lifestyle choices are key contributors to non-alcoholic fatty liver disease (NAFLD), affecting global...

Sorry! Image not available at this time

Levodopa-induced Dyskinesia Market Growth Anticipated by 2032 | Companies includes Adamas Pharmaceuticals, Acorda Therapeutics, Impel NeuroPharma, Neurocrine Biosciences, Kyowa Kirin, Sunovion Pharma

mountaintoday.in - 08:52

Levodopa-induced Dyskinesia Market DelveInsight’s analysts project market growth, fueled by increasing prevalence, improved diagnostics,...

Sorry! Image not available at this time

Levodopa-induced Dyskinesia Market Growth Anticipated by 2032 | Companies includes Adamas Pharmaceuticals, Acorda Therapeutics, Impel NeuroPharma, Neurocrine Biosciences, Kyowa Kirin, Sunovion Pharma

mountaintoday.in - 08:52

Levodopa-induced Dyskinesia Market DelveInsight’s analysts project market growth, fueled by increasing prevalence, improved diagnostics,...

Sorry! Image not available at this time

Interstitial Cystitis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest EMA, PDMA, FDA Approvals by DelveInsight | Merck & Co, Teva Pharmaceutical Industries, Integrative Therapeutics

mountaintoday.in - 04/Sep 07:57

Interstitial Cystitis market The Interstitial Cystitis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)....

Sorry! Image not available at this time

Interstitial Cystitis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest EMA, PDMA, FDA Approvals by DelveInsight | Merck & Co, Teva Pharmaceutical Industries, Integrative Therapeutics

mountaintoday.in - 04/Sep 07:57

Interstitial Cystitis market The Interstitial Cystitis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)....

Sorry! Image not available at this time

Collegium Pharma acquires Ironshore Therapeutics

pharmabiz.com - 06/Sep 00:00

Collegium Pharmaceutical Inc, a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious...

Sorry! Image not available at this time

New drug offers hope for treating rare liver disorder

knowridge.com - 08/Sep 13:48

Millions of people worldwide suffer from liver inflammation (hepatitis), which can be caused by various factors, including metabolic disorders like...

Sorry! Image not available at this time

New drug offers hope for treating rare liver disorder

knowridge.com - 08/Sep 13:48

Millions of people worldwide suffer from liver inflammation (hepatitis), which can be caused by various factors, including metabolic disorders like...

A promising new therapeutic target for MASLD identified

news.medical.net - 06:08

Using a novel stem cell platform, a team of the Medical University of South Carolina researchers has identified a pathway that could be targeted by...

Sorry! Image not available at this time

Takeda Pharmaceutical (US): Director Translational Biomarker Lead Liver disease – MASH fibrosis, ECD GI²-TAU

pharmiweb.com - 09/Sep 00:00

Competitive: Takeda Pharmaceutical (US): By clicking the "Apply" button, I understand that my employment application process with Takeda will...

Les derniers communiqués

  • Aucun élément